Print friendly version
Other Names for this Disease
- Bullous cellulitis with eosinophilia
- Eosinophilic cellulitis
- Wells' syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
In addition to treating causative factors or triggers, oral or topical corticosteroids such as Prednisone are the mainstay of therapy. Systemic corticosteroids are the most effective treatment, but they may lead to corticosteroid dependence. Other treatment options include the use of griseofulvin, H1 antihistamines, cyclosporine, and dapsone.
Last updated: 12/14/2011
- Schwartz RA. Wells Syndrome (Eosinophilic Cellulitis). eMedicine. May 2011; http://emedicine.medscape.com/article/1124844-clinical#a0218. Accessed 12/14/2011.
Clinical Trials & Research for this Disease
- The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled Evaluation and Treatment of Patients with Dermatologic Diseases which may be of interest to you. To find this trial, click on the link above.
- The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research. There is a study titled Dermatology Consultation Clinic and Clinical Research that may be of interest to you. You may want to contact the investigator, Maria Turner (firstname.lastname@example.org) to learn more.